查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2108074

低至中等通量定序儀市場到 2035 年的分析和預測：按類型、產品、服務、技術、組件、應用、流程、最終用戶、解決方案和模式。

Low to Medium Throughput Sequencer Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Process, End User, Solutions, Mode
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球中低通量定序儀市場預計將從2025年的74億美元成長到2035年的418億美元，複合年成長率（CAGR）為18.9%。中低通量定序儀的定價主要受定序精確度、樣本處理能力、自動化功能和軟體效能等因素所驅動。臨床診斷、科學研究和分散式檢查實驗室的儀器通常定價在中等水平，兼顧了價格和分析性能。整合生物資訊軟體、自動化樣品製備和更高的工作流程效率使得高階平台的定價更具優勢。耗材和試劑的銷售也佔總擁有成本的很大一部分，促使製造商採用持續的收入模式。儘管激烈的市場競爭抑制了儀器價格，但技術創新仍在不斷推動增值定價。

在應用領域，臨床診斷佔主導地位，定序被用於診斷遺傳疾病、癌症基因組學和感染疾病鑑定。精準醫療的日益普及和遺傳疾病盛行率的不斷上升是該領域的主要成長要素。包括基因組學和轉錄組學在內的研究應用也為藥物發現和開發做出了重要貢獻。定序資料與生物資訊工具的整合進一步提升了這些應用的效用。

市場區隔
類型 桌上型音序器、可攜式音序器及其他
產品 設備、試劑/耗材、軟體及其他
服務 定序服務、生物資訊服務、維護和支援等。
科技 Sanger定序、次世代定序（NGS）、單分子即時定序（SMRT）、離子半導體定序等。
成分 硬體、軟體及其他
目的 臨床診斷、基因組研究、農業與動物研究、法醫學等。
流程 樣品製備、定序、數據分析及其他相關任務。
最終用戶 學術和研究機構、製藥和生物技術公司、醫院和診所等。
解決方案 全基因測序、標靶定序、RNA定序等。
模式 自動、手動或其他

在終端用戶領域，學術和研究機構是中低通量定序儀的主要用戶，它們將其用於基礎研究和教學目的。醫療保健產業，包括醫院和診斷檢查室，也是重要的終端用戶，它們使用定序儀進行患者特異性診斷檢測。這些終端使用者群體的需求成長主要得益於合作研究計畫的增加以及政府對基因組研究的資助。

區域概覽

北美憑藉其先進的基因組研究基礎設施、強大的生物技術產業以及對精準醫療的大量投資，在低通量至中等通量測序儀市場佔主導地位。學術機構、實驗室、醫院和製藥公司廣泛利用定序平台進行臨床診斷、基因研究、腫瘤學和感染疾病研究。該地區受益於大量的政府資助、基因組技術的早期應用以及領先的定序技術供應商的存在。個人化醫療和分子診斷領域應用的不斷拓展，持續鞏固北美在全球市場的主導地位。

亞太地區預計將成為中低通量定序儀市場成長最快的地區，這主要得益於基因組研究的拓展、醫療基礎設施的改善以及生物技術投資的增加。中國、印度、日本和韓國等國家正在加強其基因組醫學能力，並擴大臨床定序的應用範圍。政府對精準醫療的支持力度加大、研究合作日益密切以及人們對基因檢測的認知不斷提高，都在加速市場成長。此外，藥物研發的擴張和定序成本的下降預計也將推動全部區域定序技術的應用。

主要趨勢和促進因素

緊湊型、去中心化的基因測序平台已廣泛應用：

醫療機構、實驗室和診斷中心正日益採用緊湊型定序系統，以縮短處理時間、簡化工作流程並降低營運成本。中低通量定序儀憑藉其柔軟性和易用性，正被廣泛應用於臨床診斷、感染疾病監測、癌症研究和學術研究等領域。此外，定序化學和自動化樣品製備技術的進步正在提高效率並擴大應用領域。這一趨勢正在顯著影響中低通量測序儀市場。

對精準醫療和臨床基因組學的需求日益成長：

隨著個人化醫療和分子診斷的日益普及，對能夠實現精準且經濟高效的基因分析的基因測序技術的需求也日益成長。中低通量定序儀在性能和價格之間實現了理想的平衡，滿足了醫院、研究機構和診斷檢查室的需求。此外，基因組研究投入的不斷增加以及疾病診斷應用範圍的不斷擴大，也持續推動市場成長。這些因素仍然是中低通量定序儀市場的主要驅動力。

目錄

第1章摘要整理

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制因素
  • 複合年均成長率分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章：細分市場分析

  • 市場規模及預測：依類型
    • 桌上型音序器
    • 可攜式音序器
    • 其他
  • 市場規模及預測：依產品分類
    • 裝置
    • 試劑和耗材
    • 軟體
    • 其他
  • 市場規模及預測：依服務分類
    • 定序服務
    • 生物資訊服務
    • 維護和支援
    • 其他
  • 市場規模及預測：依技術分類
    • 桑格定序
    • 次世代定序（NGS）
    • 單分子即時定序（SMRT）
    • 離子半導體定序
    • 其他
  • 市場規模及預測：依組件分類
    • 硬體
    • 軟體
    • 其他
  • 市場規模及預測：依應用領域分類
    • 臨床診斷
    • 基因組學研究
    • 農業/動物研究
    • 法醫學
    • 其他
  • 市場規模及預測：依最終用戶分類
    • 學術研究機構
    • 製藥和生物技術公司
    • 醫院和診所
    • 其他
  • 市場規模及預測：依製程分類
    • 圖書館調整
    • 定序
    • 數據分析
    • 其他
  • 市場規模及預測：按解決方案分類
    • 全基因測序
    • 標靶定序
    • RNA定序
    • 其他
  • 市場規模及預測：按模式
    • 自動的
    • 手動的
    • 其他

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲國家
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 其他亞太國家
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲國家

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 大公司的策略

第8章：公司簡介

  • Illumina
  • Thermo Fisher Scientific
  • Roche
  • Agilent Technologies
  • Qiagen
  • Bio-Rad Laboratories
  • PerkinElmer
  • Pacific Biosciences
  • Oxford Nanopore Technologies
  • BGI Genomics
  • Genewiz
  • Takara Bio
  • Promega Corporation
  • Fluidigm Corporation
  • 10x Genomics
  • LGC Biosearch Technologies
  • Beckman Coulter
  • Bruker Corporation
  • Nugen Technologies
  • Zymo Research

第9章 關於我們

簡介目錄
Product Code: GIS34854

The global Low to Medium Throughput Sequencer Market is projected to grow from $7.4 billion in 2025 to $41.8 billion by 2035, at a compound annual growth rate (CAGR) of 18.9%. Pricing in the low to medium throughput sequencer market is shaped by sequencing accuracy, sample processing capacity, automation features, and software capabilities. Instruments designed for clinical diagnostics, academic research, and decentralized laboratories generally occupy the mid-range pricing segment, balancing affordability with analytical performance. Integrated bioinformatics software, automated library preparation, and improved workflow efficiency justify premium pricing among advanced platforms. Consumables and reagent sales also constitute a substantial portion of total ownership costs, encouraging manufacturers to adopt recurring revenue models. Increasing competition has moderated equipment prices, although technological innovation continues to sustain value-added pricing.

The Application segment is dominated by clinical diagnostics, where sequencing is used for genetic disorder diagnosis, cancer genomics, and infectious disease identification. The growing emphasis on precision medicine and the increasing prevalence of genetic diseases are key drivers for this segment. Research applications, including genomics and transcriptomics, also contribute significantly, as they support drug discovery and development efforts. The integration of sequencing data with bioinformatics tools is enhancing the utility of these applications.

Market Segmentation
TypeBenchtop Sequencers, Portable Sequencers, Others
ProductInstruments, Reagents & Consumables, Software, Others
ServicesSequencing Services, Bioinformatics Services, Maintenance & Support, Others
TechnologySanger Sequencing, Next-Generation Sequencing (NGS), Single-Molecule Real-Time Sequencing (SMRT), Ion Semiconductor Sequencing, Others
ComponentHardware, Software, Others
ApplicationClinical Diagnostics, Genomics Research, Agricultural & Animal Research, Forensic Applications, Others
ProcessLibrary Preparation, Sequencing, Data Analysis, Others
End UserAcademic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, Others
SolutionsWhole Genome Sequencing, Targeted Sequencing, RNA Sequencing, Others
ModeAutomated, Manual, Others

Within the End User segment, academic and research institutions are the primary consumers of low to medium throughput sequencers, leveraging them for fundamental research and educational purposes. The healthcare sector, including hospitals and diagnostic laboratories, is also a significant end user, utilizing sequencers for patient-specific diagnostic tests. The rise in collaborative research projects and government funding for genomic studies is bolstering the demand from these end-user groups.

Geographical Overview

North America dominates the low to medium throughput sequencer market due to its advanced genomics research infrastructure, strong biotechnology industry, and substantial investments in precision medicine. Academic institutions, research laboratories, hospitals, and pharmaceutical companies extensively utilize sequencing platforms for clinical diagnostics, genetic research, oncology, and infectious disease studies. The region benefits from significant government funding, early adoption of genomic technologies, and the presence of leading sequencing technology providers. Growing applications in personalized medicine and molecular diagnostics continue to reinforce North America's leadership in the global market.

Asia Pacific is projected to be the fastest-growing region in the low to medium throughput sequencer market owing to expanding genomics research, improving healthcare infrastructure, and increasing investments in biotechnology. Countries such as China, India, Japan, and South Korea are strengthening genomic medicine capabilities and expanding clinical sequencing applications. Rising government support for precision healthcare, growing research collaborations, and increasing awareness of genetic testing are accelerating market growth. Furthermore, expanding pharmaceutical research and declining sequencing costs are expected to drive widespread adoption throughout the region.

Key Trends and Drivers

Growing Adoption of Compact and Decentralized Genomic Sequencing Platforms:

Healthcare providers, research laboratories, and diagnostic centers are increasingly adopting compact sequencing systems that offer faster turnaround times, simplified workflows, and lower operating costs. Low to medium throughput sequencers are becoming widely used for clinical diagnostics, infectious disease surveillance, oncology research, and academic studies due to their flexibility and accessibility. Additionally, advancements in sequencing chemistry and automated sample preparation are improving efficiency and expanding application areas. This trend is significantly shaping the low to medium throughput sequencer market.

Increasing Demand for Precision Medicine and Clinical Genomics:

The growing adoption of personalized medicine and molecular diagnostics is driving demand for genomic sequencing technologies capable of delivering accurate and cost-effective genetic analysis. Low to medium throughput sequencers provide an ideal balance between performance and affordability for hospitals, research institutions, and diagnostic laboratories. Additionally, increasing investments in genomics research and expanding applications in disease diagnosis continue to support market growth. These factors remain major drivers for the low to medium throughput sequencer market.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Process
  • 2.9 Key Market Highlights by Solutions
  • 2.10 Key Market Highlights by Mode

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Benchtop Sequencers
    • 4.1.2 Portable Sequencers
    • 4.1.3 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Instruments
    • 4.2.2 Reagents & Consumables
    • 4.2.3 Software
    • 4.2.4 Others
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Sequencing Services
    • 4.3.2 Bioinformatics Services
    • 4.3.3 Maintenance & Support
    • 4.3.4 Others
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Sanger Sequencing
    • 4.4.2 Next-Generation Sequencing (NGS)
    • 4.4.3 Single-Molecule Real-Time Sequencing (SMRT)
    • 4.4.4 Ion Semiconductor Sequencing
    • 4.4.5 Others
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Hardware
    • 4.5.2 Software
    • 4.5.3 Others
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Clinical Diagnostics
    • 4.6.2 Genomics Research
    • 4.6.3 Agricultural & Animal Research
    • 4.6.4 Forensic Applications
    • 4.6.5 Others
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Academic & Research Institutes
    • 4.7.2 Pharmaceutical & Biotechnology Companies
    • 4.7.3 Hospitals & Clinics
    • 4.7.4 Others
  • 4.8 Market Size & Forecast by Process (2020-2035)
    • 4.8.1 Library Preparation
    • 4.8.2 Sequencing
    • 4.8.3 Data Analysis
    • 4.8.4 Others
  • 4.9 Market Size & Forecast by Solutions (2020-2035)
    • 4.9.1 Whole Genome Sequencing
    • 4.9.2 Targeted Sequencing
    • 4.9.3 RNA Sequencing
    • 4.9.4 Others
  • 4.10 Market Size & Forecast by Mode (2020-2035)
    • 4.10.1 Automated
    • 4.10.2 Manual
    • 4.10.3 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 End User
      • 5.2.1.8 Process
      • 5.2.1.9 Solutions
      • 5.2.1.10 Mode
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 End User
      • 5.2.2.8 Process
      • 5.2.2.9 Solutions
      • 5.2.2.10 Mode
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 End User
      • 5.2.3.8 Process
      • 5.2.3.9 Solutions
      • 5.2.3.10 Mode
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 End User
      • 5.3.1.8 Process
      • 5.3.1.9 Solutions
      • 5.3.1.10 Mode
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 End User
      • 5.3.2.8 Process
      • 5.3.2.9 Solutions
      • 5.3.2.10 Mode
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 End User
      • 5.3.3.8 Process
      • 5.3.3.9 Solutions
      • 5.3.3.10 Mode
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 End User
      • 5.4.1.8 Process
      • 5.4.1.9 Solutions
      • 5.4.1.10 Mode
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 End User
      • 5.4.2.8 Process
      • 5.4.2.9 Solutions
      • 5.4.2.10 Mode
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 End User
      • 5.4.3.8 Process
      • 5.4.3.9 Solutions
      • 5.4.3.10 Mode
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 End User
      • 5.4.4.8 Process
      • 5.4.4.9 Solutions
      • 5.4.4.10 Mode
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 End User
      • 5.4.5.8 Process
      • 5.4.5.9 Solutions
      • 5.4.5.10 Mode
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 End User
      • 5.4.6.8 Process
      • 5.4.6.9 Solutions
      • 5.4.6.10 Mode
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 End User
      • 5.4.7.8 Process
      • 5.4.7.9 Solutions
      • 5.4.7.10 Mode
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 End User
      • 5.5.1.8 Process
      • 5.5.1.9 Solutions
      • 5.5.1.10 Mode
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 End User
      • 5.5.2.8 Process
      • 5.5.2.9 Solutions
      • 5.5.2.10 Mode
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 End User
      • 5.5.3.8 Process
      • 5.5.3.9 Solutions
      • 5.5.3.10 Mode
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 End User
      • 5.5.4.8 Process
      • 5.5.4.9 Solutions
      • 5.5.4.10 Mode
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 End User
      • 5.5.5.8 Process
      • 5.5.5.9 Solutions
      • 5.5.5.10 Mode
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 End User
      • 5.5.6.8 Process
      • 5.5.6.9 Solutions
      • 5.5.6.10 Mode
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 End User
      • 5.6.1.8 Process
      • 5.6.1.9 Solutions
      • 5.6.1.10 Mode
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 End User
      • 5.6.2.8 Process
      • 5.6.2.9 Solutions
      • 5.6.2.10 Mode
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 End User
      • 5.6.3.8 Process
      • 5.6.3.9 Solutions
      • 5.6.3.10 Mode
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 End User
      • 5.6.4.8 Process
      • 5.6.4.9 Solutions
      • 5.6.4.10 Mode
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 End User
      • 5.6.5.8 Process
      • 5.6.5.9 Solutions
      • 5.6.5.10 Mode

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Illumina
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Thermo Fisher Scientific
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Roche
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Agilent Technologies
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Qiagen
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Bio-Rad Laboratories
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 PerkinElmer
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Pacific Biosciences
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Oxford Nanopore Technologies
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 BGI Genomics
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Genewiz
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Takara Bio
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Promega Corporation
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Fluidigm Corporation
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 10x Genomics
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 LGC Biosearch Technologies
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Beckman Coulter
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Bruker Corporation
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Nugen Technologies
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Zymo Research
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us